Audience
Healthcare providers looking for a tool to identify and quantify heart attack and stroke risk with greater accuracy
About Elucid
Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.
Other Popular Alternatives & Related Software
Cleerly
Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. We design intelligent clinical technologies to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis, plaque build-up in the heart's arteries, not indirect markers such as risk factors and symptoms of the disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease diagnostics and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes. Cleerly empowers providers to go beyond traditional measures of heart disease by analyzing, characterizing, and quantifying types of plaque, so they can more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.
Learn more about Cleerly
HeartFlow
HeartFlow's non-invasive personalized cardiac test provides unprecedented visualization of each patient's coronary arteries, enabling physicians to create more effective treatment plans for their patients. The HeartFlow FFRCT Analysis starts when a patient undergoes a standard coronary computed tomography scan at a hospital or imaging center. The CT images are securely uploaded to our cloud. Next, we use advanced algorithms incorporating artificial intelligence to build a personalized, digital model of that patient’s coronary arteries. Our team of highly trained analysts then inspects this model, making any needed edits. Once this patient-specific model is completed, the HeartFlow pathway applies physiologic principles and computational fluid dynamics to compute the blood flow and FFRCT values at every point in the model. Throughout the process, we follow rigorous and well-established protocols to ensure consistent processing for every patient.
Learn more about HeartFlow
Artrya
Artrya partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Rapid assessment of chest pain patients in emergency and primary care settings. We see a world where communities do not have to be plagued by a high rate of a heart attack. AI-driven insights into the type and volume of arterial plaque detected through coronary computed tomography angiography (CCTA) facilitate the accurate stratification of chest pain patients within minutes. Quickly determine patients with minimal to zero coronary artery disease with the confidence there are no underlying plaque features that could cause future major adverse cardiac events. Catch the early warning signs of a potential heart attack. Effectively rule in at-risk patients with acute or atypical chest pain who warrant further investigation and therapy.
Learn more about Artrya
ClinCapture
At ClinCapture our mission is to build software that saves lives. Our technology lowers the cost of clinical trials by streamlining data capture processes while providing a platform that protects patient privacy. Clincapture advances the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions.
Learn more about ClinCapture
Integrations
No integrations listed.
Company Information
Elucid
United States
elucid.com
Videos and Screen Captures
Other Useful Business Software
Build Agents and Models on One Platform
Gemini Enterprise Agent Platform is Google Cloud's comprehensive platform for developers to build, scale, govern, and optimize agents and models. Choose from Google's most advanced models and third-party models like Anthropic's Claude Model Family.
Product Details
Platforms Supported
Cloud
Training
Documentation
Live Online
In Person
Videos
Support
Phone Support
Online
Elucid Frequently Asked Questions
Q: What kinds of users and organization types does Elucid work with?
Elucid works with these users and organization types: Mid Size Business, Small Business, Enterprise, Freelance, Nonprofit, Government, and Startup.
Q: What languages does Elucid support in their product?
Elucid supports these languages: English.
Q: What kind of support options does Elucid offer?
Elucid offers support via phone support and online.
Q: What type of training does Elucid provide?
Elucid provides training in the form of documentation, live online, in person, and videos.
